Biblio

Export 555 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., “Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.”, J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
J. Cummings, Ritter, A., and Zhong, K., “Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., “A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., “Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.”, J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., “The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, “Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
P. Martín-Jiménez, Muñoz-García, M. I., Seoane, D., Roca-Rodríguez, L., García-Reyne, A., Lalueza, A., Maestro, G., Folgueira, D., Blanco-Palmero, V. A., San Martín, A. Herrero-, Llamas-Velasco, S., Pérez-Martínez, D. A., González-Sánchez, M., and Villarejo-Galende, A., “Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1367-1372, 2020.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
Y. Stern, “Cognitive reserve in ageing and Alzheimer's disease.”, Lancet Neurol, vol. 11, no. 11, pp. 1006-12, 2012.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., “Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”, J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
K. Hensley and Kursula, P., “Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.”, J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., “Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1.”, J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., “Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.”, J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
M. Bisbe, Fuente-Vidal, A., López, E., Moreno, M., Naya, M., de Benetti, C., Milà, R., Bruna, O., Boada, M., and Alegret, M., “Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.”, J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
A. Sánchez, Maseda, A., M Marante-Moar, P., de Labra, C., Lorenzo-López, L., and Millán-Calenti, J. Carlos, “Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 303-15, 2016.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., “Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
N. Lelental, Brandner, S., Kofanova, O., Blennow, K., Zetterberg, H., Andreasson, U., Engelborghs, S., Mroczko, B., Gabryelewicz, T., Teunissen, C., Mollenhauer, B., Parnetti, L., Chiasserini, D., Molinuevo, J. Luis, Perret-Liaudet, A., Verbeek, M. M., Andreasen, N., Brosseron, F., Bahl, J. M. C., Herukka, S. - K., Hausner, L., Frölich, L., Labonte, A., Poirier, J., Miller, A. - M., Zilka, N., Kovacech, B., Urbani, A., Suardi, S., Oliveira, C., Baldeiras, I., Dubois, B., Rot, U., Lehmann, S., Skinningsrud, A., Betsou, F., Wiltfang, J., Gkatzima, O., Winblad, B., Buchfelder, M., Kornhuber, J., and Lewczuk, P., “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., “Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
E. Racine, Forlini, C., Aspler, J., and Chandler, J., “Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.”, J Alzheimers Dis, vol. 51, no. 1, pp. 1-9, 2016.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., “Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients.”, J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.

Pages